In a report released today, Sam Slutsky from LifeSci Capital maintained a Hold rating on InflaRx (IFRX – Research Report). The company’s shares ...

Investment analysts at Lifesci Capital issued their Q1 2025 EPS estimates for Protara Therapeutics in a note issued to ...

Liquidia Co. (NASDAQ:LQDA – Free Report) – Equities research analysts at Lifesci Capital issued their Q2 2025 earnings estimates for shares of Liquidia in a report issued on Wednesday ...

LifeSci Capital analyst Charles Zhu initiated coverage with a Buy rating on Zymeworks (ZYME – Research Report) today and set a price target of ...

Fintel reports that on March 12, 2025, LifeSci Capital initiated coverage of Monte Rosa Therapeutics (NasdaqGS:GLUE) with a ...

Brainomix, an Oxford-born company pioneering AI-powered imaging tools in stroke and lung fibrosis, has clinched an $18 ...

Fintel reports that on March 12, 2025, LifeSci Capital initiated coverage of Monte Rosa Therapeutics (NasdaqGS:GLUE) with a Outperform recommendation. As of March 4, 2025, the average one-year ...

An Oxford University spinout has secured £14 million in funding to advance its "transformative" AI imaging technology in ...

Proscia sells digital pathology software and artificial intelligence tools to pharmaceutical companies and diagnostic ...

An Oxford-based company which pioneers AI-powered imaging tools for stroke and lung fibrosis has completed a £14m Series C ...